Canada Pension Plan Investment Board’s Intellia Therapeutics NTLA Stock Holding History

Canada Pension Plan Investment Board’s Portfolio NTLA Stock Details NTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$455K	Buy	26,900 +16,800	+166%	+$235K	﹤0.01%	1297
2026 Q1	$129K	Sell	10,100 -30,300	-75%	-$386K	﹤0.01%	1628
2025 Q4	$363K	Buy	+40,400	New	+$556K	﹤0.01%	1434
2023 Q2	–	Sell	-20,100	Closed	-$749K	–	1067
2023 Q1	$749K	Buy	20,100 +16,771	+504%	+$658K	﹤0.01%	936
2022 Q4	$116K	Sell	3,329 -1,000	-23%	-$47.5K	﹤0.01%	1014
2022 Q3	$242K	Buy	4,329 +800	+23%	+$49.6K	﹤0.01%	1019
2022 Q2	$183K	Sell	3,529 -700	-17%	-$35.5K	﹤0.01%	1089
2022 Q1	$307K	Buy	+4,229	New	+$358K	﹤0.01%	1025
2021 Q4	–	Sell	-14,000	Closed	-$1.88M	–	1566
2021 Q3	$1.88M	Buy	+14,000	New	+$2.12M	﹤0.01%	857

Other funds holding NTLA

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Regeneron Pharmaceuticals Tarrytown, New York $177M AUM 9.82% 1-Year Est. Return

Canada Pension Plan Investment Board's NTLA Position: Q2 2026 in Review

Canada Pension Plan Investment Board increased its Intellia Therapeutics (NTLA) stake by 166% in Q2 2026, buying an estimated $235K and bringing the position to 26,900 shares worth $455K. The position accounts for ﹤0.01% of the portfolio, ranked #1297.

Canada Pension Plan Investment Board first reported a position in NTLA in Q3 2021 and has held it in 9 quarters since. The position peaked at $1.88M in Q3 2021. 328 funds tracked by Wall St. Rank hold NTLA as of Q2 2026.

Canada Pension Plan Investment Board held 26,900 shares of Intellia Therapeutics worth $455K as of Q2 2026.
Canada Pension Plan Investment Board bought 16,800 Intellia Therapeutics shares in Q2 2026, an estimated $235K.
Intellia Therapeutics made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #1297 holding.
Canada Pension Plan Investment Board first reported a position in Intellia Therapeutics in Q3 2021 and has held it in 9 quarters since.
Canada Pension Plan Investment Board's Intellia Therapeutics position peaked at $1.88M in Q3 2021.
328 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.